Hint mode is switched on Switch off

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
154.38 USD
NAV per Share | 17/07/2026
31/01/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
10,528.64 mln USD
Fund NAV | 17/07/2026
10,528.64 mln USD
Share Class NAV | 17/07/2026
No
UCITS
1 / 3 (11/09/2015)
Split

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 17/07/2026, NYSE Arca

  • YTD
    5.06 %
  • 1M
    -7.93 %
  • 3M
    1.65 %
  • 6M
    11.2 %
  • 1Y
    62.15 %
  • 3Y
    51.47 %
  • 5Y
    0.91 %
  • 10Y
    143.19 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XBI)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI on 16/07/2026

Download structure in Excel
Paper Value
APOGEE THERAPEUTICS INC 1.59%
KYMERA THERAPEUTICS INC 1.43%
ERASCA INC 1.4%
MODERNA INC 1.35%
TWIST BIOSCIENCE CORP 1.32%
VIKING THERAPEUTICS INC 1.29%
ORUKA THERAPEUTICS INC 1.27%
PRAXIS PRECISION MEDICINES I 1.26%
CG ONCOLOGY INC 1.24%
SPYRE THERAPEUTICS INC 1.23%
MIRUM PHARMACEUTICALS INC 1.23%
PROTAGONIST THERAPEUTICS INC 1.23%
DIANTHUS THERAPEUTICS INC 1.23%
NATERA INC 1.22%
REVOLUTION MEDICINES INC 1.22%
RHYTHM PHARMACEUTICALS INC 1.22%
VAXCYTE INC 1.21%
RELAY THERAPEUTICS INC 1.21%
COGENT BIOSCIENCES INC 1.19%
CYTOKINETICS INC 1.18%
ROIVANT SCIENCES LTD 1.17%
BRIDGEBIO PHARMA INC 1.17%
ALKERMES PLC 1.16%
TRAVERE THERAPEUTICS INC 1.16%
TG THERAPEUTICS INC 1.16%
SCHOLAR ROCK HOLDING CORP 1.15%
INSMED INC 1.15%
MADRIGAL PHARMACEUTICALS INC 1.14%
ABBVIE INC 1.11%
REGENERON PHARMACEUTICALS 1.11%
GILEAD SCIENCES INC 1.1%
VERTEX PHARMACEUTICALS INC 1.1%
ULTRAGENYX PHARMACEUTICAL IN 1.09%
INCYTE CORP 1.09%
AMGEN INC 1.08%
HALOZYME THERAPEUTICS INC 1.08%
KRYSTAL BIOTECH INC 1.07%
BIOGEN INC 1.06%
PTC THERAPEUTICS INC 1.05%
BIOMARIN PHARMACEUTICAL INC 1.05%
NEUROCRINE BIOSCIENCES INC 1.05%
EXELIXIS INC 1.04%
VERA THERAPEUTICS INC 1.02%
GRAIL INC 1.01%
SUMMIT THERAPEUTICS INC 1.01%
ACADIA PHARMACEUTICALS INC 1.01%
SELLAS LIFE SCIENCES GROUP I 1%
ARROWHEAD PHARMACEUTICALS IN 0.99%
IMMUNOVANT INC 0.99%
CELCUITY INC 0.98%
CRISPR THERAPEUTICS AG 0.97%
UNITED THERAPEUTICS CORP 0.96%
ALNYLAM PHARMACEUTICALS INC 0.96%
BEAM THERAPEUTICS INC 0.95%
DYNE THERAPEUTICS INC 0.93%
UNIQURE NV 0.93%
IMMUNITYBIO INC 0.92%
VERACYTE INC 0.87%
BIOCRYST PHARMACEUTICALS INC 0.86%
IDEAYA BIOSCIENCES INC 0.82%
ARCUTIS BIOTHERAPEUTICS INC 0.8%
SYNDAX PHARMACEUTICALS INC 0.79%
TANGO THERAPEUTICS INC 0.79%
DENALI THERAPEUTICS INC 0.78%
AGIOS PHARMACEUTICALS INC 0.77%
SAREPTA THERAPEUTICS INC 0.76%
MINERALYS THERAPEUTICS INC 0.75%
IONIS PHARMACEUTICALS INC 0.73%
CELLDEX THERAPEUTICS INC 0.71%
VIRIDIAN THERAPEUTICS INC 0.7%
DISC MEDICINE INC 0.69%
ARCUS BIOSCIENCES INC 0.68%
ADMA BIOLOGICS INC 0.68%
INTELLIA THERAPEUTICS INC 0.67%
IOVANCE BIOTHERAPEUTICS INC 0.67%
RECURSION PHARMACEUTICALS A 0.66%
IMMUNOME INC 0.66%
NOVAVAX INC 0.61%
KODIAK SCIENCES INC 0.61%
PALVELLA THERAPEUTICS INC 0.6%
VERICEL CORP 0.56%
NURIX THERAPEUTICS INC 0.56%
BIOHAVEN LTD 0.53%
MONTE ROSA THERAPEUTICS INC 0.48%
VIR BIOTECHNOLOGY INC 0.46%
CAREDX INC 0.46%
STOKE THERAPEUTICS INC 0.45%
TYRA BIOSCIENCES INC 0.44%
HYPERLIQUID STRATEGIES 0.42%
ANAPTYSBIO INC 0.42%
ABSCI CORP 0.42%
CORVUS PHARMACEUTICALS INC 0.41%
CAPRICOR THERAPEUTICS INC 0.41%
CULLINAN THERAPEUTICS INC 0.39%
ZENAS BIOPHARMA INC 0.38%
ARDELYX INC 0.38%
ANNEXON INC 0.36%
AVALO THERAPEUTICS INC 0.36%
INHIBRX BIOSCIENCES INC 0.35%
PRECIGEN INC 0.35%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.